Evidence map›Paper›PMID 35344551›Full record

ArticlePLoS neglected tropical diseases2022

Health care cost of crusted scabies in Aboriginal communities in the Northern Territory, Australia.

Margaret Campbell, Naomi van der Linden, Karen Gardner, Helen Dickinson, Jason Agostino, Michelle Dowden, Irene O'Meara, Meg Scolyer, Hannah Woerle, Rosalie Viney and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Scabies.Nature reviews. Disease primers · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Margaret CampbellCentre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Sydney, Australia.
Naomi van der LindenDepartment of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.ORCID 0000-0003-1646-9834
Karen GardnerPublic Service Research Group, School of Business, UNSW Canberra, Canberra, Australia.ORCID 0000-0001-9783-3575
Helen DickinsonPublic Service Research Group, School of Business, UNSW Canberra, Canberra, Australia.ORCID 0000-0003-3852-8815
Jason AgostinoAcademic Unit of General Practice, Australian National University, Canberra, Australia.ORCID 0000-0001-7937-6526
Michelle DowdenOne Disease, Darwin, Australia.
Irene O'MearaOne Disease, Darwin, Australia.ORCID 0000-0003-4920-9676
Meg ScolyerOne Disease, Darwin, Australia.
Hannah WoerleOne Disease, Darwin, Australia.ORCID 0000-0002-1900-1391
Rosalie VineyCentre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Sydney, Australia.
Kees van GoolCentre for Health Economics Research and Evaluation, Faculty of Health, University of Technology Sydney, Sydney, Australia.ORCID 0000-0002-1424-9304
Charles Darwin University · AUUniversity of Technology Sydney · AUUniversity of Canberra · AUAustralian National University · AUUniversity of Twente · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCrusted scabies is a debilitating dermatological condition. Although still relatively rare in the urban areas of Australia, rates of crusted scabies in remote Aboriginal communities in the Northern Territory (NT) are reported to be among the highest in the world.

objectiveTo estimate the health system costs associated with diagnosing, treating and managing crusted scabies.

methodsA disease pathway model was developed to identify the major phases of managing crusted scabies. In recognition of the higher resource use required to treat more severe cases, the pathway differentiates between crusted scabies severity grades. The disease pathway model was populated with data from a clinical audit of 42 crusted scabies patients diagnosed in the Top-End of Australia's Northern Territory between July 1, 2016 and May 1, 2018. These data were combined with standard Australian unit costs to calculate the expected costs per patient over a 12-month period, as well as the overall population cost for treating crusted scabies.

findingsThe expected health care cost per patient diagnosed with crusted scabies is $35,418 Australian dollars (AUD) (95% CI: $27,000 to $43,800), resulting in an overall cost of $1,558,392AUD (95% CI: $1,188,000 to $1,927,200) for managing all patients diagnosed in the Northern Territory in a given year (2018). By far, the biggest component of the health care costs falls on the hospital system. DISCUSSION: This is the first cost-of-illness analysis for treating crusted scabies. Such analysis will be of value to policy makers and researchers by informing future evaluations of crusted scabies prevention programs and resource allocation decisions. Further research is needed on the wider costs of crusted scabies including non-financial impacts such as the loss in quality of life as well as the burden of care and loss of well-being for patients, families and communities.

Indexed as

ScabiesHealth Care CostsHumansIndigenous PeoplesNorthern TerritoryQuality of Life

Identifiers

PMID35344551
PMCPMC8989313
OpenAlexW4221051287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.